U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    PTP4A1 protein tyrosine phosphatase 4A1 [ Homo sapiens (human) ]

    Gene ID: 7803, updated on 17-Jun-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Endothelial PTP4A1 mitigates vascular inflammation via USF1/A20 axis-mediated NF-kappaB inactivation.

    Endothelial PTP4A1 mitigates vascular inflammation via USF1/A20 axis-mediated NF-κB inactivation.
    Cho MJ, Lee DG, Lee JW, Hwang B, Yoon SJ, Lee SJ, Park YJ, Park SH, Lee HG, Kim YH, Lee CH, Lee J, Lee NK, Han TS, Cho HS, Moon JH, Lee GS, Bae KH, Hwang GS, Lee SH, Chung SJ, Shim S, Cho J, Oh GT, Kwon YG, Park JG, Min JK., Free PMC Article

    08/25/2023
    GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1.

    GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1.
    Hu H, Ye L, Liu Z., Free PMC Article

    04/2/2022
    LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.

    LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
    Li O, Jiang B, Yi WM, Zhang Y, Yang PZ, Guo C, Sun ZP, Peng C.

    01/8/2022
    These results provide evidence indicating a regulatory role of PRL-1 during Immunological Synapse assembly and highlight the involvement of PRLs in immune responses by mature T cells.

    Phosphatase of Regenerating Liver-1 (PRL-1) Regulates Actin Dynamics During Immunological Synapse Assembly and T Cell Effector Function.
    Castro-Sánchez P, Ramirez-Munoz R, Martín-Cófreces NB, Aguilar-Sopeña O, Alegre-Gomez S, Hernández-Pérez S, Reyes R, Zeng Q, Cabañas C, Sánchez-Madrid F, Roda-Navarro P., Free PMC Article

    10/5/2019
    Overexpression of miR-339-5p enhanced radiosensitivity of A549 and H460 cells by inhibiting cell viability, increasing apoptosis, inducing cell cycle arrest, and suppressing cell proliferation. Further exploration validated that miR-339-5p can target phosphatases of regenerating liver-1 (PRL-1) in lung cancer cells.

    miR-339-5p Increases Radiosensitivity of Lung Cancer Cells by Targeting Phosphatases of Regenerating Liver-1 (PRL-1).
    Wang J, Jiang M, Xia S., Free PMC Article

    02/2/2019
    PRL mRNA transcription was stimulated by Mg(2+) depletion. A series of analyses revealed the activation and the crucial importance of signal transducer and activator of transcription 1 in this process. Collectively, these results implicate PRL in maintaining cellular Mg(2+) homeostasis.

    Phosphatase of regenerating liver maintains cellular magnesium homeostasis.
    Yoshida A, Funato Y, Miki H.

    01/12/2019
    PTP4A1 is a direct downstream target of miR-1271 in the hepatocellular carcinoma.

    MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the PTP4A1/c-Src axis.
    Li C, Jiang Y, Miao R, Qu K, Zhang J, Liu C.

    08/11/2018
    PTP4A1 is highly expressed in fibroblasts from patients with systemic sclerosis and enhances pro-fibrotic TGFbeta signaling in these cells.

    PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis.
    Sacchetti C, Bai Y, Stanford SM, Di Benedetto P, Cipriani P, Santelli E, Piera-Velazquez S, Chernitskiy V, Kiosses WB, Ceponis A, Kaestner KH, Boin F, Jimenez SA, Giacomelli R, Zhang ZY, Bottini N., Free PMC Article

    05/5/2018
    PTP4A1 was overexpressed in ICC and played an important role in the progression and metastasis of ICC. The functional role of PTP4A1 was assumed to be acted by activation PI3K/AKT signaling and promoting the EMT process through two pivotal transcriptional factors Zeb1 and Snail.

    Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ, He YZ, Dong PP, Ma LJ, Wang ZC, Liu XY, Duan M, Yang LX, Shi JY, Zhou J, Fan J, Gao Q, Wang XY., Free PMC Article

    03/3/2018
    Results showed that SIAH1 and PTP4A1 expression was regulated by mir-944 in breast cancer cells. miR-944 binds directly the 3 UTR of their promotor region.

    Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.
    Flores-Pérez A, Marchat LA, Rodríguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D, Maciel-Dominguez A, de la Cruz OH, Fonseca-Sánchez M, Ruíz-García E, la Vega HA, López-Camarillo C., Free PMC Article

    10/21/2017
    miR-601 inhibits growth and invasion of breast cancer cells by targeting PTP4A1.

    miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
    Hu JY, Yi W, Wei X, Zhang MY, Xu R, Zeng LS, Huang ZJ, Chen JS.

    12/31/2016
    Data indicate that protein-tyrosine-phosphatase of regenerating liver 1 (PRL1) gene was expressed much more highly in prostate cancer (PCa) than in nonneoplastic prostate samples.

    Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
    Shinmei S, Sentani K, Hayashi T, Sakamoto N, Goto K, Oo HZ, Naito Y, Teishima J, Matsubara A, Oue N, Kuniyasu H, Yasui W.

    05/16/2015
    Upregulation of PRL-1 expression is inversely correlated with miR-26a in primary cervical cancer tissues.

    MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
    Dong J, Sui L, Wang Q, Chen M, Sun H.

    05/16/2015
    Data highlight the oncogenic function of PRL-1 in HCC invasion and metastasis.

    Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma.
    Jin S, Wang K, Xu K, Xu J, Sun J, Chu Z, Lin D, Koeffler PH, Wang J, Yin D., Free PMC Article

    04/25/2015
    We confirmed with our previous findings that PTP4A1-PHF3-EYS variants were significantly associated with alcohol dependence.

    Common PTP4A1-PHF3-EYS variants are specific for alcohol dependence.
    Zuo L, Wang K, Wang G, Pan X, Zhang X, Zhang H, Luo X., Free PMC Article

    02/28/2015
    PTP4A1-PHF3-EYS variants were associated with alcohol dependence.

    Association of rare PTP4A1-PHF3-EYS variants with alcohol dependence.
    Zuo L, Zhang X, Deng HW, Luo X.

    11/30/2013
    Results suggest that TRP32 maintains the reduced state of PRL and thus regulates the biological function of PRL.

    Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).
    Ishii T, Funato Y, Miki H., Free PMC Article

    05/4/2013
    Studies indicate that PRL-1 and PRL-2 and PRL-3 are oncogenes and belong to the few phosphatases that lead to the development of cancer.

    Molecular mechanisms of the PRL phosphatases.
    Rios P, Li X, Köhn M.

    04/13/2013
    upregulation of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma

    Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.
    Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ, Su WW, Hu RM.

    08/18/2012
    Data conclude that the PHF3-PTP4A1 region appears to harbor a causal locus for alcohol dependence, and proteins encoded by PHF3 and/or PTP4A1 might play a functional role in the disorder.

    A novel, functional and replicable risk gene region for alcohol dependence identified by genome-wide association study.
    Zuo L, Zhang CK, Wang F, Li CS, Zhao H, Lu L, Zhang XY, Lu L, Zhang H, Zhang F, Krystal JH, Luo X., Free PMC Article

    04/14/2012
    PRL-1 binding to p115 RhoGAP provides a coordinated mechanism underlying ERK1/2 and RhoA activation

    PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein.
    Bai Y, Luo Y, Liu S, Zhang L, Shen K, Dong Y, Walls CD, Quilliam LA, Wells CD, Cao Y, Zhang ZY., Free PMC Article

    02/25/2012
    Meta-analysis of gene-disease association. (HuGE Navigator)

    Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
    Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G, Ovarian Cancer Association Consortium, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer)., Free PMC Article

    09/15/2010
    Increased PRL1 expression results in activation of Src and ERK1/2, which stimulates MMP2 and MMP9 production, leading to increased cell migration and invasion.

    PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
    Luo Y, Liang F, Zhang ZY., Free PMC Article

    06/28/2010
    phosphatase of regenerating liver activity is controlled by the redox environment and its C-terminal residues

    Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.
    Skinner AL, Vartia AA, Williams TD, Laurence JS., Free PMC Article

    01/21/2010
    the new oncogenic p53 target, PRL-1, may contribute to tumor development by the downregulation of p53 by a negative feedback mechanism.

    New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53.
    Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J, Han YM, Kim IC, Yoo OJ.

    01/21/2010
    firstprevious page of 2 nextlast